Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides

Bibliographic Details
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219840/?tool=EBI
_version_ 1817983054643200000
collection DOAJ
first_indexed 2024-04-13T23:28:48Z
format Article
id doaj.art-5025502c93d742d6bdbaaff0c476ae25
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T23:28:48Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5025502c93d742d6bdbaaff0c476ae252022-12-22T02:24:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01911Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotideshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219840/?tool=EBI
spellingShingle Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
PLoS ONE
title Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
title_full Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
title_fullStr Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
title_full_unstemmed Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
title_short Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
title_sort correction reversing multidrug resistance in caco 2 by silencing mdr1 mrp1 mrp2 and bcl 2 bcl xl using liposomal antisense oligonucleotides
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219840/?tool=EBI